Published in:

22-05-2023 | Mood Disorders | Original Article

Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study

Authors: Zhen Peng, Xiaoyu Zhu, Chongwei Wang, Mingfeng Zhou, Xiaoling Xu, Yin Chen

Published in: Annals of Hematology | Issue 7/2023

Abstract

Hemophilia patients enrolled in clinical trials often exhibit various physical and psychological symptoms. However, little is known about anxiety and depression among them. This study assessed the effects of depression and anxiety on hemophilia patients enrolled in clinical trials and identified risk factors for these disorders. A multi-center, cohort study was conducted from January to December 2022. Sixty-nine hemophilia patients who enrolled in clinical trials participated at baseline (T1, prior to treatment initiation) and completed the informed consent. Risk factors were measured at baseline to predict depression and anxiety at 3 months (T2). Sixty-four hemophilia patients were included in the final analysis. More hemophilia patients had moderate-severe depression (28 [43.75%]) and anxiety (16 [25.00%]) at T2 than at T1 (12 [18.75]), (5 [7.81%]). Depression was aggravated in 23 (35.94%) patients and anxiety was aggravated in 12 (18.75%) patients. Frequently acquired medical information (OR 11.378, CI 1.319–98.114, P = 0.027), baseline GAD-7 (OR 1.341, CI 1.015-1.772, P = 0. 039) and PHQ-9 (OR 1.465, CI 1.039-2.065, P = 0.029) are important factors predicting depression and anxiety in hemophilia patients. Hemophilia patients enrolled in a clinical trial have significant anxiety and depression. The frequency of acquiring medical information and the baseline PHQ-9 and GAD-7 scores were risk factors for anxiety and depression. Thus, hemophilia patients should receive education regarding clinical trials and undergo evaluations of their anxiety and depression; these changes will enable prompt detection of their psychological burden and identify potential psychological intervention strategies.

Bolton-Maggs PH, Pasi KJ (2003) Haemophilias A and B. Lancet 361(9371):1801–1809. https://doi.org/10.1016/S0140-6736(03)13405-8CrossRefPubMed

Forsyth AL, Gregory M, Nugent D, Garrido C, Pilgaard T, Cooper DL, Iorio A (2014) Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia 20(1):44–51. https://doi.org/10.1111/hae.12239CrossRefPubMed

Dimichele DM, Blanchette V, Berntorp E (2012) Clinical trial design in haemophilia. Haemophilia 18(Suppl 4):18–23. https://doi.org/10.1111/j.1365-2516.2012.02824.xCrossRefPubMed

Fletcher S, Jenner K, Pembroke L, Holland M, Khair K (2022) The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet J Rare Dis 17(1):155. https://doi.org/10.1186/s13023-022-02256-2CrossRefPubMedPubMedCentral

Auerswald G, Šalek SZ, Benson G, Elezović I, Lambert T, Morfini M, Pasi J, Remor E, Santagostino E, Salaj P, Ljung R (2012) Beyond patient benefit: clinical development in hemophilia. Hematology 17(1):1–8. https://doi.org/10.1179/102453312x13221316477372CrossRefPubMed

Banchev A, Batorova A, Faganel Kotnik B, Kiss C, Puras G, Zapotocka E, Zupancic-Salek S, Patient Advocacy G (2021) A cross-national survey of people living with hemophilia: impact on daily living and patient education in Central Europe. Patient Prefer Adherence 15:871–883. https://doi.org/10.2147/PPA.S303822CrossRefPubMedPubMedCentral

Hughes T, Brok-Kristensen M, Gargeya Y, Lottrup AMW, Larsen AB, Torres-Ortuño A, Mackett N, Stevens J (2020) “What more can we ask for?”: an ethnographic study of challenges and possibilities for people living with haemophilia %J The Journal of Haemophilia. Practice. 7(1):25–36. https://doi.org/10.17225/jhp00151CrossRef

Wang M, Peltier S, Baumann K, Sidonio RF Jr, Witkop M, Cooper DL, Waters EK, Kahan S (2020) Awareness, Care and Treatment In Obesity Management to inform Haemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): results of a survey of US haemophilia treatment centre professionals. Haemophilia 26(Suppl 1):20–30. https://doi.org/10.1111/hae.13919CrossRefPubMed

Forsyth AL, Witkop M, Lambing A, Garrido C, Dunn S, Cooper DL, Nugent DJ (2015) Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study. Patient Prefer Adherence 9:1549–1560. https://doi.org/10.2147/ppa.S87659CrossRefPubMedPubMedCentral

10.

Flood E, Pocoski J, Michaels LA, Bell JA, Valluri S, Sasanè R (2014) Illustrating the impact of mild/moderate and severe haemophilia on health-related quality of life: hypothesised conceptual models. Eur J Haematol 93(Suppl 75):9–18. https://doi.org/10.1111/ejh.12328CrossRefPubMed

11.

Kim SY, Kim SW, Kim JM, Shin IS, Baek HJ, Lee HS, Hwang TJ, Yoon JS (2013) Impact of personality and depression on quality of life in patients with severe haemophilia in Korea. Haemophilia 19(5):e270–e275. https://doi.org/10.1111/hae.12221CrossRefPubMed

12.

Witkop ML, Lambing A, Nichols CD, Munn JE, Anderson TL, Tortella BJ (2019) Interrelationship between depression, anxiety, pain, and treatment adherence in hemophilia: results from a US cross-sectional survey. Patient Prefer Adherence 13:1577–1587. https://doi.org/10.2147/ppa.S212723CrossRefPubMedPubMedCentral

13.

Buckner TW, Witkop M, Guelcher C, Frey MJ, Hunter S, Peltier S, Recht M, Walsh C, Kessler CM, Owens W, Clark DB, Frick N, Rice M, Iyer NN, Holot N, Cooper DL, Sidonio R Jr (2017) Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study. Eur J Haematol 98(Suppl 86):5–17. https://doi.org/10.1111/ejh.12854CrossRefPubMed

14.

duTreil S (2014) Physical and psychosocial challenges in adult hemophilia patients with inhibitors. J Blood Med 5:115–122. https://doi.org/10.2147/jbm.S63265CrossRefPubMedPubMedCentral

15.

Kneckt MC, Keinänen-Kiukaanniemi SM, Knuuttila ML, Syrjälä AM (2001) Self-esteem as a characteristic of adherence to diabetes and dental self-care regimens. J Clin Periodontol 28(2):175–180. https://doi.org/10.1034/j.1600-051x.2001.028002175.xCrossRefPubMed

16.

Canclini M, Saviolo-Negrin N, Zanon E, Bertoletti R, Girolami A, Pagnan A (2003) Psychological aspects and coping in haemophilic patients: a case-control study. Haemophilia 9(5):619–624. https://doi.org/10.1046/j.1365-2516.2003.00807.xCrossRefPubMed

17.

Cassis FR, Querol F, Forsyth A, Iorio A, Board HIA (2012) Psychosocial aspects of haemophilia: a systematic review of methodologies and findings. Haemophilia 18(3):e101–e114. https://doi.org/10.1111/j.1365-2516.2011.02683.xCrossRefPubMed

18.

Spilsbury M (2004) Models for psychosocial services in the developed and developing world. Haemophilia 10(Suppl 4):25–29. https://doi.org/10.1111/j.1365-2516.2004.01002.xCrossRefPubMed

19.

Iannone M, Pennick L, Tom A, Cui H, Gilbert M, Weihs K, Stopeck AT (2012) Prevalence of depression in adults with haemophilia. Haemophilia 18(6):868–874. https://doi.org/10.1111/j.1365-2516.2012.02863.xCrossRefPubMed

20.

Robbertz AS, Weiss DM, Awan FT, Byrd JC, Rogers KA, Woyach JA (2020) Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia. Support Care Cancer 28(4):1799–1807. https://doi.org/10.1007/s00520-019-04991-yCrossRefPubMed

21.

Cassis FR, Buzzi A, Forsyth A, Gregory M, Nugent D, Garrido C, Pilgaard T, Cooper DL, Iorio A (2014) Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia 20(4):e287–e295. https://doi.org/10.1111/hae.12454CrossRefPubMed

22.

Motlagh H (2010) Impact of Event Scale-revised. J Physiother 56(3):203. https://doi.org/10.1016/s1836-9553(10)70029-1CrossRefPubMed

23.

Tavane PN, Raghuveer HP, Kumar RD, Shobha ES, Rangan V, Dutt CS (2013) Validation of a Kannada version of the Impact of Events Scale (IES). J Int Oral Health 5(5):38–47PubMedPubMedCentral

24.

Wu KK, Chan KS (2003) The development of the Chinese version of Impact of Event Scale--Revised (CIES-R). Soc Psychiatry Psychiatr Epidemiol 38(2):94–98. https://doi.org/10.1007/s00127-003-0611-xCrossRefPubMed

25.

Mundy-Bosse BL, Thornton LM, Yang HC, Andersen BL, Carson WE (2011) Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunol 270(1):80–87. https://doi.org/10.1016/j.cellimm.2011.04.003CrossRefPubMedPubMedCentral

26.

Jacobsen PB (2004) Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:93–97. https://doi.org/10.1093/jncimonographs/lgh010CrossRef

27.

Yang M, Chen S, Wan Y, Hu X (2020) Psychometric properties of the Multidimensional Fatigue Inventory-10 in breast cancer patients. Contemp Nurse 56(1):90–100. https://doi.org/10.1080/10376178.2020.1742178CrossRefPubMed

28.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. https://doi.org/10.1093/jnci/85.5.365CrossRefPubMed

29.

Artherholt SB, Hong F, Berry DL, Fann JR (2014) Risk factors for depression in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant 20(7):946–950. https://doi.org/10.1016/j.bbmt.2014.03.010CrossRefPubMedPubMedCentral

30.

Thong ISK, Jensen MP, Miró J, Tan G (2018) The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain 18(1):99–107. https://doi.org/10.1515/sjpain-2018-0012CrossRefPubMed

31.

Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.xCrossRefPubMedPubMedCentral

32.

Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32(15):1605–1619. https://doi.org/10.1200/jco.2013.52.4611CrossRefPubMedPubMedCentral

33.

O'Hara S, Castro FA, Black J, Chaplin S, Ruiz L, Hampton RJ, Sima CS, O'Hara J (2021) Disease burden and remaining unmet need in patients with haemophilia A treated with primary prophylaxis. Haemophilia 27(1):113–119. https://doi.org/10.1111/hae.14171CrossRefPubMed

34.

Palareti L, Melotti G, Cassis F, Nevitt SJ, Iorio A (2020) Psychological interventions for people with hemophilia. Cochrane Database Syst Rev 3(3):Cd010215. https://doi.org/10.1002/14651858.CD010215.pub2CrossRefPubMed

35.

Lim Y, Lim JM, Jeong WJ, Lee KH, Keam B, Kim TY, Kim TM, Han SW, Oh DY, Kim DW, Kim TY, Heo DS, Bang YJ, Im SA (2017) Korean cancer patients’ awareness of clinical trials, perceptions on the benefit and willingness to participate. Cancer Res Treat 49(4):1033–1043. https://doi.org/10.4143/crt.2016.413CrossRefPubMedPubMedCentral

36.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224. https://doi.org/10.1007/s00520-014-2571-yCrossRefPubMed

37.

Santavirta N, Björvell H, Solovieva S, Alaranta H, Hurskainen K, Konttinen YT (2001) Coping strategies, pain, and disability in patients with hemophilia and related disorders. Arthritis Rheum 45(1):48–55. https://doi.org/10.1002/1529-0131(200102)45:1<48::Aid-anr83>3.0.Co;2-1CrossRefPubMed

Title: Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study
Authors: Zhen Peng
Xiaoyu Zhu
Chongwei Wang
Mingfeng Zhou
Xiaoling Xu
Yin Chen
Publication date: 22-05-2023
Publisher: Springer Berlin Heidelberg
Keywords: Mood Disorders
Hemophilia
Affective Disorder
Anxiety
Published in: Annals of Hematology / Issue 7/2023
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-023-05277-4

Comparison of survival outcomes of different treatment modalities for patients with primary splenic diffuse large B cell lymphoma

Lymphoma
Original Article

Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience

Open Access
Autoimmune Hemolytic Anemia
Original Article

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response

Open Access
Chronic Myeloid Leukemia
Correction

G6PD deficiency—does it alter the course of COVID-19 infections?

Open Access
SARS-CoV-2
Review Article

A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients

Acute Lymphoblastic Leukemia
Original Article

Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis

Lymphoma
Original Article

Keynote series | Spotlight on managing health in obesity

Obesity
Video Series

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman

Prof. Jonette Keri

Developed by: Springer Medicine

Watch now

Women’s health knowledge hub

Menopause
Clinical Collection

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Live
Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital

Prof. Ronald F. van Vollenhoven

Developed by: Springer Medicine

Keynote series | Spotlight on managing health in obesity

Springer Medicine

Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study

Abstract

Other articles of this Issue 7/2023

Comparison of survival outcomes of different treatment modalities for patients with primary splenic diffuse large B cell lymphoma

Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response

G6PD deficiency—does it alter the course of COVID-19 infections?

A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients

Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis

Keynote series | Spotlight on managing health in obesity

Women’s health knowledge hub

Keynote webinar | Spotlight on advances in lupus

Springer Medicine

Abstract

Please log in to get access to this content